Efficacy of Bevacizumab Alone or in Combination with Temozolomide and Irinotecan in the Treatment of Recurrent and Refractory Brain Tumors in Children in Lebanon

Noun P.; Fadlallah M.; Hmaimess G.; Younis J. Abi; Hage P.; Al Hamod D.; Mansour H.; Bechara E.

首页> 外文期刊>Pediatric blood & cancer >Efficacy of Bevacizumab Alone or in Combination with Temozolomide and Irinotecan in the Treatment of Recurrent and Refractory Brain Tumors in Children in Lebanon

【24h】

Efficacy of Bevacizumab Alone or in Combination with Temozolomide and Irinotecan in the Treatment of Recurrent and Refractory Brain Tumors in Children in Lebanon

机译：贝伐单抗单独或与替替莫酮和伊立替康组合治疗黎巴嫩儿童复发和难治性脑肿瘤的疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第s4期|共2页
作者
Noun P.; Fadlallah M.; Hmaimess G.; Younis J. Abi; Hage P.; Al Hamod D.; Mansour H.; Bechara E.;
展开▼
作者单位

St George Hosp UMC Pediat Hematol Oncol Unit Beirut Lebanon;

Lebanese Hosp Geitaoui UMC Pediat Hematol Oncol Unit Beirut Lebanon;

St George Hosp UMC Pediat Neuro Metab Unit Beirut Lebanon;

Lebanese Hosp Geitaoui UMC Pediat Hematol Oncol Unit Beirut Lebanon;

St George Hosp UMC Dept Neurosurg Beirut Lebanon;

St George Hosp UMC Pediat Intens Care Unit Beirut Lebanon;

St George Hosp UMC Pediat Neuro Metab Unit Beirut Lebanon;

St George Hosp UMC Pediat Hematol Oncol Unit Beirut Lebanon;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of Bevacizumab Alone or in Combination with Temozolomide and Irinotecan in the Treatment of Recurrent and Refractory Brain Tumors in Children in Lebanon [J] . Noun P., Fadlallah M., Hmaimess G., Pediatric blood & cancer . 2019,第S4期

机译：贝伐单抗单独或与替替莫酮和伊立替康组合治疗黎巴嫩儿童复发和难治性脑肿瘤的疗效
2. Phase Ⅱ study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study [J] . Jacques Grill, Birgit Geoerger, Lyle Gesner, Neuro-Oncology . 2013,第9期

机译：伊立替康联合替莫唑胺（TEMIRI）治疗复发性或难治性髓母细胞瘤患儿的Ⅱ期临床研究：ITCC和SIOPE联合研究
3. Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors [J] . WagnerL., TurpinB., NagarajanR., Pediatric blood & cancer . 2013,第9期

机译：长春新碱，口服伊立替康和替莫唑胺（VOIT方案）联合贝伐单抗在小儿复发性实体瘤或脑瘤患者中的初步研究
4. REPRODUCIBILITY STUDY OF PREDICTION OF BRAIN TUMORS RESPONSE TO BEVACIZUMAB TREATMENT [C] . Neda Behzadfar, Hamid Soltanian-Zadeh 2011 international conference on medical information and bioengineering. . 2011

机译：预测贝伐单抗治疗的脑肿瘤的可重复性研究
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study [O] . Jacques Grill, Birgit Geoerger, Lyle Gesner, 2013

机译：伊立替康联合替莫唑胺（TEMIRI）治疗复发性或难治性髓母细胞瘤患儿的II期临床研究：联合ITCC和SIOPE脑肿瘤研究
7. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study [O] . Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, 2013

机译：Bevacizumab Plus Irinotecan在患有复发性低级胶质瘤儿童的疗效 - 儿科脑肿瘤联盟研究

Efficacy of Bevacizumab Alone or in Combination with Temozolomide and Irinotecan in the Treatment of Recurrent and Refractory Brain Tumors in Children in Lebanon

著录项

相似文献

相关主题

期刊订阅